Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-CE22-007: Reduce Health Disparities and Improve Traumatic Brain Injury (TBI) Related Outcomes Through the Implementation of CDC's Pediatric Mild TBI Guideline; Amended Notice of Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

February 1, 2022

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Full Text

<html>
<head>
<title>Federal Register, Volume 87 Issue 21 (Tuesday, February 1, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 21 (Tuesday, February 1, 2022)]
[Notices]
[Page 5483]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-01950]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--CE22-007: Reduce Health Disparities and Improve 
Traumatic Brain Injury (TBI) Related Outcomes Through the 
Implementation of CDC's Pediatric Mild TBI Guideline; Amended Notice of 
Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--CE22-007: Reduce Health Disparities and Improve Traumatic Brain 
Injury (TBI) Related Outcomes Through the Implementation of CDC's 
Pediatric Mild TBI Guideline; June 6-7, 2022, 8:30 p.m.-5:30 p.m., EDT, 
Videoconference.
    The Videoconference meeting was published in the Federal Register 
on January 14, 2022, Volume 87, Number 10, page 2438.
    The meeting is being amended to correct the dates of the special 
emphasis panel and should read as follows:
    Date: June 7-8, 2022.
    The meeting is closed to the public.
    For Further Information Contact: Mikel Walters, Ph.D., Scientific 
Review Official, National Center for Injury Prevention and Control, 
CDC, 4770 Buford Highway NE, Mailstop F-63, Atlanta, Georgia 30341, 
Telephone (404) 639-0913, <a href="/cdn-cgi/l/email-protection#602d37010c14051213200304034e070f16"><span class="__cf_email__" data-cfemail="b0fde7d1dcc4d5c2c3f0d3d4d39ed7dfc6">[email&#160;protected]</span></a>.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-01950 Filed 1-31-22; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on February 1, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.